Low-dose lipopolysaccharide (LPS) inhibits aggressive and augments depressive behaviours in a chronic mild stress model in mice by Couch, Yvonne et al.
RESEARCH Open Access
Low-dose lipopolysaccharide (LPS) inhibits
aggressive and augments depressive
behaviours in a chronic mild stress model
in mice
Yvonne Couch1†, Alexander Trofimov2,3,4†, Natalyia Markova3,4†, Vladimir Nikolenko5, Harry W. Steinbusch3,
Vladimir Chekhonin6, Careen Schroeter7, Klaus-Peter Lesch2,3, Daniel C. Anthony1* and Tatyana Strekalova3*
Abstract
Background: Aggression, hyperactivity, impulsivity, helplessness and anhedonia are all signs of depressive-like
disorders in humans and are often reported to be present in animal models of depression induced by stress or by
inflammatory challenges. However, chronic mild stress (CMS) and clinically silent inflammation, during the recovery
period after an infection, for example, are often coincident, but comparison of the behavioural and molecular
changes that underpin CMS vs a mild inflammatory challenge and impact of the combined challenge is largely
unexplored. Here, we examined whether stress-induced behavioural and molecular responses are analogous to
lipopolysaccharide (LPS)-induced behavioural and molecular effects and whether their combination is adaptive or
maladaptive.
Methods: Changes in measures of hedonic sensitivity, helplessness, aggression, impulsivity and CNS and systemic
cytokine and 5-HT-system-related gene expression were investigated in C57BL/6J male mice exposed to chronic
stress alone, low-dose LPS alone or a combination of LPS and stress.
Results: When combined with a low dose of LPS, chronic stress resulted in an enhanced depressive-like phenotype
but significantly reduced manifestations of aggression and hyperactivity. At the molecular level, LPS was a strong
inducer of TNFα, IL-1β and region-specific 5-HT2A mRNA expression in the brain. There was also increased serum
corticosterone as well as increased TNFα expression in the liver. Stress did not induce comparable levels of cytokine
expression to an LPS challenge, but the combination of stress with LPS reduced the stress-induced changes in 5-HT
genes and the LPS-induced elevated IL-1β levels.
Conclusions: It is evident that when administered independently, both stress and LPS challenges induced distinct
molecular and behavioural changes. However, at a time when LPS alone does not induce any overt behavioural
changes per se, the combination with stress exacerbates depressive and inhibits aggressive behaviours.
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Background
The association between depression and inflammation
has been recognized for some time [1, 2]. Indeed, clinical
trials have reported antidepressant treatment effects for
anti-inflammatory agents such as non-steroidal anti-
inflammatory drugs (NSAIDs), and pro-inflammatory
cytokine inhibitors have also shown antidepressant treat-
ment effects compared to placebo. Tumour necrosis fac-
tor alpha (TNFα) blockade, for example, improved
depressive symptoms in patients with treatment-
resistant depression, but only in patients with high base-
line CRP levels [3], suggesting that the anti-
inflammatory therapy targets processes independent of
the etiological mechanisms underlying major depressive
disorder (MDD). However, the additive nature of
inflammation-induced depressive-like behaviours when
combined with MDD highlights that inflammation is
likely to be clinically relevant tractable target in many
clinical forms of depression. However, while the impact
of inflammatory challenges on the negative affect com-
ponent of depression has been examined, the impact of
inflammation on other accompanying behaviours has
often been overlooked. Aberrant social behaviours, par-
ticularly aggression, as well as psychomotor agitation,
often accompany depression and stress-related condi-
tions in man and rodents [4–6]. Indeed, aggressive be-
haviour during major depression is associated with an
enhanced risk of suicide [7]. Altered neuroimmune re-
sponses are also known to contribute to the neurobiol-
ogy of aggression [8], and pro-inflammatory cytokine
production, in particular, has been implicated in the
mechanisms underpinning the stress response [5, 9] as
well as aggressive behaviour [10–13].
Human and animal studies have linked aggression and
impulsivity to the increased production of certain in-
flammatory mediators [11, 14]. In particular, aggressive
traits in humans have been associated with increased
serum TNFα [12], C-reactive protein [15] and other cy-
tokines [16]. Indeed, patients in whom cytokines have
been therapeutically administered often display signs of
aggression [17, 18]. Furthermore, systemic expression of
inflammatory mediators, such as increased systemic
interleukin-1 beta (IL-1β) and interleukin-6 (IL-6), are
associated with locomotor agitation during aging [11].
Conversely, mice selectively bred for high levels of ag-
gression also display increased cytokine levels [19] and
knockout of both TNFα-receptor-1 and TNFα-receptor-
2 abrogates aggressive behaviours [20] suggesting that
overall, cytokines and aggressive behaviours are linked.
The finding that stress is associated with the induction
of inflammation [21–23] could be interpreted in evolu-
tionary terms, as a coherent mechanism to enhance sur-
vival. Stressors, such as predation, could potentially lead
to injury and infection. Thus, pre-activation of the
immune system would theoretically enhance survival
and recovery [24].
In humans, parallels to the sickness behaviour ob-
served upon systemic infection in rodents clearly exist.
Interferon (IFN) therapy is known to induce transient
signs of depression or malaise [25], and systemic inflam-
matory diseases are known to be accompanied by
depressive-like signs [26, 27]. In rodents, CNS expres-
sion of pro-inflammatory cytokines IL-1β and TNFα
contribute to anhedonia and behavioural measures of
helplessness after chronic stress [28, 29]. Pro-
inflammatory changes are associated with altered seroto-
nergic function [30], over-expression of the 5-HT2A re-
ceptor and over-expression of the serotonin transporter
(SERT) [29], which together with other 5-HT-related el-
ements underlie mechanisms of depressive symptoms
and social dominancy [31]. Despite this, it remains un-
clear at what level and to what extent sickness behav-
iours and depression converge and how similar the
underlying molecular profile is. For example, the impact
of inflammation-induced depressive-like behaviour com-
pared with chronic stress on measures of aggression and
impulsivity or hyperactivity has been largely overlooked.
Irrespective of whether the pathways leading to such ab-
errant behaviours are distinct, it is clear that a ‘double-
hit’ of stress and infection impacts on the pathogenesis
of depression [32, 33].
In the current study, we sought to determine the de-
gree to which the behaviours associated with chronic
mild stress (CMS) may be influenced by a mild, low-
dose lipopolysaccharide (LPS) challenge that does not
normally give rise to anything other than transient and
subtle changes in behaviour that persist for no more
than a couple of hours. MDD is a disease that is charac-
terized by a recurrent episode of depression, but it is
often unclear what factors might have precipitated re-
lapse. Here, we were interested to discover how the sin-
gle LPS challenge would impact on behaviour in a pre-
stressed animal at a time when the effect of LPS had re-
solved. In this way, it is possible to evaluate the residual
effects of acute inflammation on stress-induced behav-
ioural changes. We examined behavioural parameters of
aggression and impulsivity/hyperactivity, anhedonia and
helplessness, as well as the expression of inflammatory
and serotonergic markers of the periphery and specific
brain areas, including the medial pre-frontal cortex and
hippocampus as these sites are well recognized to play a
crucial role in the stress response [34], and we have pre-
viously found that 5-HT2A and SERT expression levels
change in response to systemic inflammation [35] and
chronic stress paradigms [29] in these regions.
A 10-day stress procedure was selected in the present
study because it has been previously shown to induce a
depressive-like syndrome in mice, which is accompanied
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by changes in CNS serotonergic and pro-inflammatory
genes [29, 36]. Previous work in rats has shown that re-
peated LPS challenges, sufficient to induce sickness be-
haviour, when combined with chronic mild stress can
induce additive increases in plasma corticosterone and
TNFα in rats will enhance depressive-like behaviour
[37]. In contrast to these findings in rats, our investi-
gations have established, using a single low-dose LPS
(0.1 mg/kg) in CMS mice and a broader set of behav-
ioural tests, that there is no simple additive effect
when inflammation and stress are combined but high-
light selective independent effects on a number of
stress-related behaviours and on the underlying mo-
lecular biology.
Methods
Animals
Studies were performed using 3.5-month-old male
C57BL/6J mice; 3.5-month-old male CD1 mice were
used as intruders for social stress, and 2–5-month-old
Wistar rats were used for predator stress. All animals
were supplied by the Gulbenkian Institute of Science,
Oeiras, Portugal. C57BL/6J mice were housed individu-
ally for 14 days before the start of the experiments; CD1
mice and rats were housed in groups of five before the
experiment and then individually thereafter. All animals
were kept under a reversed 12-h light-dark cycle (lights
on: 21:00 h) with food and water ad libitum, under con-
trolled laboratory conditions (22 ± 1 °C, 55 % humidity).
A minimum of six animals were used in all the behav-
ioural experiments, and a minimum of five animals per
group were used in the molecular biology experiments.
All studies were carried out in accordance with the
European Communities Council Directive for the care
and use of laboratory animals upon approval by the eth-
ics committee of Maastricht University for animal re-
search (CPV, DEC-UM 2009-109) and permission 0421/
000/000/2013 issued by the General Directory of Ethical
Committee of the New University of Lisbon.
Study outline
The study design is outlined in the schematic in Fig. 1,
and the animals were randomly assigned to test groups.
The behavioural responses were studied in three separate
A
B
Fig. 1 Schematic outline of the behavioural studies for a LPS-challenged stress-naïve mice and b LPS-challenged or vehicle-challenged stressed/
non-stressed animals compared with control animals. The numbers in each group and total numbers are shown
Couch et al. Journal of Neuroinflammation  (2016) 13:108 Page 3 of 17
cohorts. The first cohort was used to establish a sub-
threshold working dose of LPS that would not induce al-
tered behaviour in the elevated O-maze and resident-
intruder test in naïve mice, so that we would be able to
explore the interaction of stress and LPS (Fig. 1a). A lack
of immediate behavioural effects with 0.1 mg/kg LPS and
a suppression of social and locomotor behaviour with
0.5 mg/kg LPS has been previously reported [38, 39]. The
animals were subjected to either an acute LPS challenge,
0.5 or 0.1 mg/kg, or treated with vehicle alone and tested
24 h post-injection or, in order to explore the delayed be-
havioural response to LPS [40], 48 h post-injection, in sep-
arate subgroups. The second cohort (Fig. 1b) was
subjected to chronic mild stress or no stress (minimal
handling). Separate subgroups of mice were subjected to
the novel cage, O-maze, forced swim test and a resident-
intruder test or sucrose test and tail suspension or were
killed for analysis of central and peripheral changes in
gene expression and blood corticosterone. The stressed
and non-stressed animals were then subsequently treated
with either LPS at 0.1 mg/kg or vehicle 24 h prior to test-
ing. The number of animals per group is indicated in the
figure legends. A third cohort, duplicating the first, was
employed to establish the effects of 0.1 and 0.5 mg/kg LPS
on behaviour in the open field at 24 or 48 h post-injection
using TruScan apparatus. Resting time and average speed
were recorded.
Acute LPS challenge
The animals were exposed to a single dose of LPS either
24 or 48 h prior to behavioural testing in the novel cage,
O-maze or resident-intruder test. LPS (E. coli 0111:B4,
Sigma-Aldrich) was made as a stock solution in sterile
saline (0.9 %) and injected intraperitoneally (i.p.) at 0.1
or 0.5 mg/kg in a volume of 0.1 ml. Control animals re-
ceived a single i.p. dose of saline (0.1 ml) to control for
injection stress.
Chronic mild stress
In the second (stressed) cohort, the animals underwent a
previously validated 10-day chronic stress procedure
[41]. The stress procedure consisted of rat exposure be-
tween the hours of 18:00 and 09:00 h (light phase of
dark-light cycle) concomitant with a combination of re-
straint stress for 2 h and tail suspension for 40 min, ap-
plied in a semi-random manner with an inter-session
interval of at least 4 h [29]. Briefly, during predation
stress, mice were introduced to a transparent glass cylin-
der (15 cm high × ⌀ 8 cm) and placed into the rat cage for
15 h as described and validated previously [39, 40, 42]. For
a restraint stress, mice were placed into a small container
(50-ml Falcon tube) with space for breathing but no space
for free movement, for 2 h, and for tail suspension, they
were hung by their tails during the dark phase of the
animals’ light cycle, as described previously [29]. Body
weight, sucrose preference and previously defined social be-
haviour parameters were determined 1 week before the
chronic stress procedure [38, 39, 41]. A further cohort of an-
imals were killed, and tissue was collected for messenger
RNA (mRNA) analysis.
Behavioural testing
Behaviour was tested after 24 h because at this point,
LPS-induced behavioural changes in stress-naïve mice
had returned to baseline for the low-dose LPS challenge
(Fig. 2). All behavioural testing was carried out during
the dark phase of the animals’ light-dark cycle. Tests
were recorded on film and analysis carried out post hoc
and blinded, unless otherwise stated in the text.
Elevated O-maze
The apparatus (Technosmart, Rome, Italy) consisted of a
circular path (runway width 5.5 cm, diameter 46 cm)
that was placed 45 cm above the floor. Two opposing
arms were protected by walls (closed area, height
10 cm), and the illumination strength was 25 lx. The ap-
paratus was placed on a dark surface in order to main-
tain control over lighting conditions during testing. Mice
were placed in one of the closed-arm area of the appar-
atus. Behaviour was assessed using previously validated
parameters during a 5-min observation period [36, 43].
The latency of the first exit to the ‘open’ compartments
of the maze, the number of exits to the open arms and
the percentage of time spent in the open arms were re-
corded [28].
Resident-intruder test
The resident-intruder test procedure was adapted
from previously described protocols [36, 44]. In this
paradigm, the C57BL/6J mice were placed individu-
ally in an observation cage (30 × 60 × 30 cm) for
30 min to acclimatize. Thereafter, a previously
group-housed male CD1 mouse was introduced as
an intruder to the same cage and left with the resi-
dent mouse for 8 min. During the observation
period, both resident mice were scored for the la-
tency and duration of social interaction (nose-nose
interactions) as well as the latency to attack, the
number of attacks and the duration of crawl over
behaviour. Crawl over time was recorded when the
resident mouse positioned itself on top of the in-
truder mouse and often was usually associated with
paw pressure on the head of the intruder [45]. Dur-
ing these periods, the intruder mouse showed little,
if any, resistance to this mounting and displayed a
submission by closing the eyes and not moving.
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Novel cage test
The novel cage test was performed to assess exploration
in a new environment as described elsewhere [44, 46].
Mice were introduced into a standard plastic cage (21 ×
21 × 15 cm) filled with fresh sawdust. The number of ex-
ploratory rears was counted under red light during a 5-
min period.
Open field TruScan
Mice were placed into TruScan activity boxes (26 × 26 ×
39 cm; Coulbourn) for 10 min. The boxes were evenly
illuminated with white light at 25 lx. Horizontal move-
ments (speed) and resting time were scored automatic-
ally by red beam cells using TruScan software
(Coulbourn), as described elsewhere [47]. Mean speed
and total duration of resting behaviour, defined by a lack
of crossing of more than three beams over 60 s, were
evaluated.
Sucrose preference
Mice were given 24 h of free choice between two bottles
of either 1 % sucrose or standard drinking water, as de-
scribed elsewhere [44]. The bottles were weighed before
and after conducting the sucrose preference and con-
sumption calculated accordingly. The beginning of the
test started with the onset of the dark (active) phase of
the animals’ cycle. To prevent the possible effects of side
preference in drinking behaviour, the position of the bot-
tles in the cage was switched at 12 h, halfway through
testing. No prior food or water deprivation was applied
before the test. Other conditions of the test were applied
as described elsewhere [48]. Both baseline and post-
A B
C D
E F
Fig. 2 The effect of low doses of LPS on behavioural outcomes at 24 and 48 hours post-challenge innaïve mice. Animals were subjected to a
single dose of LPS: 0.1 mg/kg or 0.5 mg/kg (n=7 in each group)or vehicle administration (n=6), and were tested 24 h or 48 h thereafter in the
elevated O-maze for (a) latency to exit to open arm, (b) number of exits into open arms, and (c) the time spent in the open arms. Subsequently,
mice were observed for (d) latency and (e) duration of social interaction in a resident-intruder test. Mean speed (f) was also recorder in the open
field. Data are mean ± SEM; *p < 0.05 when compared to control animals
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stress paradigm sucrose preference tests utilized a 1 %
sucrose solution. Percentage preference for sucrose was
calculated at the end of the test using the following for-
mula: Sucrose Preference = VolumeSucrose solution/(Volu-
meSucrose solution + VolumeWater) × 100.
Tail suspension test
The protocol used in this study was adapted from a pre-
viously validated procedure [43, 47]. Mice were sus-
pended by the tails to a rod 50 cm above the floor using
adhesive tape. Animals were left on this apparatus for
6 min in a dark room. The apparatus was illuminated
with a single spotlight (5 lx at animal height). The trials
were recorded by a video camera positioned directly in
front of the mice while the experimenter observed the
session from a distance in a dark area of the experimen-
tal room. The total duration of this behaviour, a putative
measure of ‘behavioural despair’, were scored using pro-
tocols that were previously validated with automated
tools [43, 47]. In accordance with the commonly ac-
cepted criteria, immobility was defined as the absence of
any movements of the animals’ head and body.
Forced swim test
The protocol used for the Porsolt forced swim test was
modified to prevent behavioural artefacts caused by
stress-induced hyperlocomotion [41]. Mice were placed
into a transparent pool (20 × 35 × 15 cm) lit with red
light and filled with warm water (30 °C, to a depth of
9.5 cm) for 2 min. Floating behaviour, commonly inter-
preted as ‘behavioural despair’ in mice [49], was defined
as the absence of directed movements of the animals’
head and body. Floating was measured by visual obser-
vation which was validated previously in comparison to
automated scoring with specialized software [43, 47].
The latency to begin floating was scored as the time
between introduction of the animal into the pool and
the first moment of complete immobility of the entire
body for a duration of >3 s. The total time spent
floating was scored for the entire duration of the test
using video footage.
Tissue collection
Mice were terminally anaesthetized with an intraperito-
neal injection of sodium pentobarbitone. The left ven-
tricle was perfused in situ with 10 ml ice-cold saline; the
brain and liver of each mouse were dissected. The pre-
frontal cortex and striatum were collected by placing the
brain, on its ventral side, on a metal plate. The olfactory
bulbs were removed, and a 1-mm-thick coronal section
of the most anterior cortical tissue was collected. The
left and right cortical sections were further dissected to
take the medial pre-frontal cortex while avoiding the
motor cortex and anterior forceps of the corpus
callosum. The left and right striatum was collected by
generating a coronal section at bregma 0 and bregma
+1. The cortex and corpus callosum were carefully re-
moved and the left and right striatum collected. The
hippocampus was removed by generating a coronal slice
at bregma −1 and bregma −3. The overlying cortex was
carefully removed, and the left and right hippocampus
was removed. The dorsal raphe nucleus was collected
from a 1-mm-thick section from bregma −4 to bregma
−5 by collecting a diamond-shaped piece of tissue under
the fourth ventricle. Small segments of liver tissue were
isolated and stored at −80 °C.
Quantitative RT-PCR (qPCR)
RNA extraction was performed as previously described
from specifically microdissected snap-frozen brain re-
gions and liver biopsies using the RNeasy Mini Kit
(Qiagen, UK) [29]. The serotonergic genes 5-HT2A and
SERT were selected for analysis based on prior observa-
tion that their expression levels change in response to
systemic inflammation [35] and chronic stress paradigms
[29]. Primers were custom designed and synthesized,
taking basic secondary structure into account during the
design process (PrimerDesign Ltd., UK). All primers
were validated against a standard complementary DNA
(cDNA) biobank (PrimerDesign) to ensure adequate
amplification and single melt-curve products. Five hun-
dred nanograms of whole mRNA was converted to
cDNA using random primers supplied with the High
Capacity Reverse Transcription cDNA Kit (Applied Bio-
systems, UK), and final samples were diluted to 5 ng/μl.
Standard curves were generated from a mixed cohort of
cDNA, and analysis was performed using SYBR green
(PrimerDesign Ltd., Southampton, UK) and a LightCy-
cler 480 (Roche, UK). Cycle conditions were 8-min en-
zyme activation (95 °C), 15-s denaturation (95 °C),
followed by 40 cycles of denaturation (15 s at 95 °C) and
data collection (45 s at 60 °C). Total cDNA was used to
enable normalization to expression of the housekeeping
gene glyceraldehyde-3-phosphate (GAPDH) using the
Pfaffl method [50]. Details of primers are listed in
(Additional file 1: Table S1). Results are expressed as
relative-fold compared to control animals.
Corticosterone high-performance liquid chromatography
(HPLC)
Blood was taken via cardiac puncture immediately be-
fore perfusion and stored in heparinized vials prior to
centrifugation (10 k rpm, 10 min, 4 °C), and plasma was
removed and immediately stored at −20 °C. Cortico-
sterone was analysed using HPLC coupled with mass
spectroscopy, based on the principles from Marwah
et al. [51]. Briefly, plasma samples were diluted 1:1 with
distilled water and applied to 2 ng of internal standard
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(5-pregnen-3b-ol-20-one-16a-carbonitrile). Diethyl ether
was added to separate organic compounds into a water-
free layer. Samples were vortexed and centrifuged
(5 min, 1500×g) to fully separate solvent and aqueous
layers. Solvent layers were removed and dried using a
heated vacuum centrifuge. Organic residues were dis-
solved in 100 μl eluent A (see below) and applied to col-
umns. Separations were carried out using a Waters 2695
separations module (Waters, Elstree, UK) with an ACE
C18 3 μm, 100 × 2.1 mm column (Hichrom, Reading)
maintained at 35 °C. The specific eluents were 2 mM
acetic acid (A) and acetonitrile (B), with a linear gradient
of 30–75 % of B over 8 min. The flow rate was 0.25 ml/
min. The eluent was monitored using a Waters Micro-
mass ZQ mass detector using positive electrospray
ionization in single ion mode and Waters Empower 2
software. Mass spectrometry was performed under the
following conditions: capillary voltage, 2.7 kV; source
temperature, 125 °C; desolvation temperature, 475 °C;
desolvation gas flow, 575 l/h; and cone gas flow, 80 l/h.
Corticosterone was monitored at m/z 347.1 (M +H),
cone voltage 20 V. The internal standard CA4 was mon-
itored at m/z 302.1, cone voltage 35 V.
Statistics
Data were analysed using GraphPad Prism version 6.0
for Windows (San Diego, CA) and InVivoStat software.
Two-way ANOVA and RM-ANOVA were used followed
by post hoc tests as appropriate (Bonferroni) and as in-
dicated in the text. The level of confidence was set at
95 % (p < 0.05), and data are shown as mean ± SEM.
Results
A low dose of LPS of 0.1 mg/kg has no significant
behavioural effects in naïve mice
Naive mice were challenged with either 0.1 or 0.5 mg/kg
LPS to determine the behavioural effects of each dose 24
or 48 h thereafter [35]. In the elevated O-maze, there
was a main effect of LPS dose, but not time post-
challenge, on the overall latency to exit to the open arms
(Fig. 2a; two-way ANOVA dose p < 0.01 F2,34 = 7.89; time
post-challenge p = 0.06 F1,34 = 0.55; dose:time post-
challenge p = 0.78 F2,34 = 0.25). Post hoc analysis demon-
strates that at 24 h post-challenge, 0.5 mg/kg LPS
animals have a significantly increased latency to exit to
the open arms compared to controls (Fig. 2a; Bonferroni
p < 0.05). The total number of exits from the closed area
of the O-maze was not affected by either LPS dose or
time (Fig. 2b; two-way ANOVA dose p = 0.93 F2,34 =
0.07; time post-challenge p = 0.28 F1,34 = 1.18; dose:time
post-challenge p = 0.07 F2,34 = 2.90). There was a non-
significant tendency for the higher dose of LPS to affect
the total number of exits at 24 h post-challenge; this was
not significant (Fig. 2b; p = 0.07). The proportion of time
spent in the open arms of the elevated O-maze was also
unaffected by treatment (Fig. 2c; two-way ANOVA dose
p = 0.60 F2,34 = 0.5.14; time post-challenge p = 0.25 F1,34 =
1.343; dose:time post-challenge p = 0.63 F2,34 = 0.455).
In the resident-intruder test, there was no overall
effect of dose or time on social interaction (Fig. 2d; two-
way ANOVA dose p = 0.31 F2,34 = 1.18; time post-
challenge p = 0.16 F1,34 = 2.06; dose:time post-challenge
p = 0.13 F2,34 = 2.14), but post hoc testing showed a sig-
nificantly increased latency of social interaction in ani-
mals receiving 0.5 mg/kg and tested at 24 h when
compared to vehicle-treated controls (Fig. 2d; Bonferroni
p < 0.05). The total time spent interacting with the in-
truder was also not affected by LPS at either 24 or 48 h
(Fig. 2e; two-way ANOVA dose p = 0.07 F2,34 = 2.89; time
post-challenge p = 0.26 F1,34 = 1.27; dose:time post-
challenge p = 0.57 F2,34 = 0.57). Using open field and
novel cage tests, we observed no effect of either dose on
locomotor activity on mean speed (Fig. 2f; two-way
ANOVA dose p = 0.77 F2,34 = 0.257; time post-challenge
p = 0.47 F1,34 = 0.53; dose:time post-challenge p = 0.90
F2,34 = 0.10) or on resting time or the number of rears
(Additional file 1: Figure S1).
Stress-induced depressive-like behaviours tend to be
exacerbated by systemic inflammation
Since the lower dose of LPS did not affect the behaviour
of naïve mice at 24 h, it was used for the chronic stress
study. We first assessed body weight (experimental
groups were balanced at baseline) and showed that stress
reduced body weight as expected (Additional file 1: Fig-
ure S2). Low-dose LPS (0.1 mg/kg) given 24 h prior to
testing does not significantly alter parameters of sucrose
preference test (Additional file 1: Figure S2) [41]. How-
ever, it was hypothesized that if stress increases pro-
inflammatory cytokines, stimulation of the system with
an inflammatory challenge may significantly alter this
behaviour. All animals showed a preference of >65 % for
a 1 % sucrose solution prior to testing and a consistent
sucrose and water intake (Additional file 1: Figure S2 C–
E). Control animals, and animals injected 24 h prior to
testing with 0.1 mg/kg LPS, maintained a sucrose prefer-
ence of >65 % and were not significantly different from
each other (Fig. 3a). After 10 days of chronic stress,
there was a significant main effect of stress on sucrose
consumption but not of LPS, and there was no inter-
action between stress and LPS (Fig. 3a; two-way
ANOVA; stress p < 0.001 F1,54 = 16.62; LPS p = 0.28 F1,54
= 1.182; stress:LPS p = 0.41 F1,54 = 0.689). Consistent
with the main effects, post hoc tests showed that after
10 days of chronic stress and a single i.p. dose of saline,
animals displayed a significant decrease (<65 %) prefer-
ence for a sucrose solution (Fig. 3a; Bonferroni post hoc
p < 0.05). Post hoc analysis revealed that animals
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undergoing 10 days of chronic stress combined with a
single i.p. dose of LPS (0.1 mg/kg) 24 h prior to testing
also showed a decrease in sucrose preference compared
to controls (p < 0.001). While there appears to be a de-
crease in sucrose preference for stressed animals receiv-
ing LPS compared to those without LPS, this difference
is not significant (p = 0.192). Since sample sizes are un-
equal across groups, post hoc tests should be considered
with caution. Total sucrose intake somewhat reflects
this, here showing a main effect of both stress and LPS
but no interaction (Fig. 3b; two-way ANOVA; stress p <
0.001 F1,54 = 25.36; LPS p < 0.01 F1,54 = 10.27; stress:LPS
p = 0.28 F1,54 = 1.15). Post hoc testing revealed a signifi-
cant decrease in sucrose consumption in stressed ani-
mals when compared to non-stressed controls (Fig. 3b;
Bonferroni post hoc p < 0.01). Post hoc testing also re-
veals a decreased sucrose intake in stressed mice treated
with LPS when compared to those treated with vehicle,
suggesting a higher degree of anhedonia in these animals
(Fig. 3b; Bonferroni post hoc p < 0.0001). Finally, stressed
mice show some degree of hyperdipsia, with water con-
sumption being affected by stress, but not by any other
factors (Fig. 3c; two-way ANOVA; stress p < 0.05 F1,54 =
5.38; LPS p = 0.31 F1,54 = 1.04; stress:LPS p = 0.35 F1,54 =
0.85).
Tail suspension is used to measure helpless behaviour,
which is associated with a depressive-like state in mice
[52, 53]. Analysis showed a significant effect of stress on
the total time spent immobile in the test (Fig. 3d; two-
way ANOVA; stress p < 0.001 F1,40 = 24.89; LPS p = 0.16
F1,40 = 1.97; stress:LPS p = 0.35 F1,40 = 0.89) but no other
main effects and no interactions. Post hoc testing
showed that all stressed animals, irrespective of treat-
ment, were immobile for significantly longer periods
than controls (Fig. 3d; Bonferroni post hoc; stress p <
0.05; stress and LPS p < 0.0001).
A B
C D
E F
Fig. 3 The effect of low-dose LPS on depressive-like behaviours in stressed mice. Naïve and stressed animals were subjected to either a single
dose of LPS (0.1 mg/kg) or vehicle injection and tested 24 h thereafter in a two-bottle sucrose preference test investigating a overall preference
for sucrose, b total sucrose consumption, c water intake in a sucrose test, d the period of immobility in the tail suspension test, and in the forced
swim test for e latency to floating and f total time spent floating. All animals showed >65 % preference for sucrose at baseline and similar sucrose
preference prior to bolus injection of LPS or vehicle (Additional file 1: Figure S2). Data are mean ± SEM; *p < 0.05, **p < 0.01 and ***p < 0.001 when
compared to controls; +p < 0.05 and +++p < 0.001 compared to stressed animals
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In the forced swim test, another test for helpless be-
haviour, control and LPS-alone animals showed similar
values in both the latency to float and total time spent
floating. Analysis showed that both stress and LPS had a
main effect on the latency to floating behaviour but that
there was no interaction between factors and therefore,
all results should be considered with caution (Fig. 3e;
two-way ANOVA; stress p < 0.001 F1,43 = 21.46; LPS p <
0.05 F1,43 = 5.495; stress:LPS p = 0.19 F1,43 = 1.76). In post
hoc tests, chronic stress significantly decreased the la-
tency to float compared to controls (Fig. 3e; Bonferroni
post hoc; p < 0.05), as did chronic stress combined with
LPS (p < 0.001). Using multiple pairwise comparisons
(Bonferroni post hoc), LPS combined with stress is sig-
nificantly different from stress alone (p < 0.05); however,
as there is no interaction between these factors, this re-
sult should be interpreted with caution.
There was a main effect of stress, not LPS, on the total
duration of floating behaviour, and there was no inter-
action between factors (two-way ANOVA; stress F1,43 =
9.654, p < 0.01; LPS F1,43 = 1.922, p = 0.17; stress: LPS
F1,43 = 0.99, p = 0.32; Fig. 3f ). In post hoc tests, the com-
bination of chronic stress and LPS significantly increased
the total time spent floating compared to the control
group in the forced swim test (Fig. 3f; Bonferroni post
hoc; p < 0.05). While this suggests that LPS combined
with stress significantly affects floating behaviour in the
forced swim test, the lack of interaction makes these re-
sults difficult to interpret.
Inflammation decreases aggression and impulsivity in
stressed animals
In the O-maze, stress and LPS significantly affected the
latency to exit into the open arms independently and
through interaction (Fig. 4a; two-way ANOVA; stress
F1,39 = 4.41, p < 0.05; LPS F1,39 = 9.84, p < 0.01; stress:
LPS F1,39 = 4.87, p < 0.05). In stressed animals, LPS re-
versed the stress-induced decrease in the latency to exit
to the open arms, ameliorating this parameter which is
an assumed sign of impulsivity (Fig. 4a; Bonferroni post
hoc; p < 0.001). Similarly, the total number of exits to
the open arms of the maze was significantly affected by
stress and LPS independently and in terms of interaction
(Fig. 4b; two-way ANOVA; stress F1,39 = 4.55, p < 0.05;
LPS F1,39 = 4.58, p < 0.05; stress: LPS F1,39 = 5.01, p <
0.05). Post hoc testing also demonstrated that the pres-
ence of LPS significantly diminished the number of exits
to the open arms of the O-maze in stressed animals,
thus abolishing the impulsivity/hyperlocomotion in these
mice (Fig. 4b; Bonferroni post hoc; p < 0.01).
The resident-intruder test can be used to assess both
social and aggressive behaviours [54]. Resident-intruder
testing was performed on all animals before undertaking
the chronic stress and/or dosing procedure, and all
groups were shown to be balanced at baseline (Add-
itional file 1: Figure S3). We found that the duration of
social exploration was significantly decreased by LPS
and there was also an interaction between stress and
LPS (Fig. 4d; two-way ANOVA; stress F1,35 = 1.17, p =
0.28; LPS F1,35 = 18.81, p < 0.0001; stress: LPS F1,35 =
10.15, p < 0.01). Post hoc testing found that stressed ani-
mals challenged with LPS interacted with their intruders
for significantly less time than those not challenged with
LPS (Fig. 4d; Bonferroni post hoc; p < 0.0001).
When aggressive behaviour was examined, we found
that the 10 days of chronic stress increased crawl over
behaviour and the number of attacks and this was sig-
nificantly inhibited by LPS treatment (Fig. 4). LPS treat-
ment affected the number of the total number of attacks
compared to control animals in an independent fashion,
and analysis revealed a further interaction with stress
(Fig. 4e; two-way ANOVA; stress F1,35 = 1.89, p = 0.17;
LPS F1,35 = 7.16, p < 0.01; stress: LPS F1,35 = 4.39, p <
0.05). LPS significantly reduced the stress-induced rise
in the number of attacks analysed with post hoc testing
(Fig. 4e; Bonferroni post hoc; p < 0.001). Crawl over be-
haviour, a measure of a dominant-like interaction [45],
was found to be increased in the animals exposed to
stress, and this was once more significantly reduced in
the stressed animals that were challenged with LPS
(Fig. 4f; RM-ANOVA; stress/LPS treatment F3,35 = 3.59,
p < 0.05; before/after F1,35 = 2.85, p = 0.1; stress/LPS: be-
fore/after F3,35 = 6.78, p < 0.01). Stressed animals showed
an increased amount of crawl over behaviour when com-
pared to controls (Fig. 4f; Bonferroni post hoc p < 0.01).
Furthermore, stressed animals treated with LPS showed
significantly less crawl over behaviour when compared
to animals that had undergone stress alone (Fig. 4f; Bon-
ferroni post hoc p < 0.0001).
Behaviour in a novel cage was also examined in all ani-
mals. Those animals undergoing 10 days of chronic
stress followed by either an LPS challenge or a vehicle
challenge showed no significant change in rearing behav-
iour in this test (two-way ANOVA; stress F1,32 = 1.29,
p = 0.26; LPS F1,32 = 0.01, p = 0.9; stress: LPS F1,32 = 0.17,
p = 0.67). This suggests that the changes observed in be-
havioural tests for aggression or social interaction above
were unlikely to be a result of confounding alterations in
general locomotor activity (Additional file 1: Figure S2).
Inflammation and stress cumulatively increase hepatic
IL-1β, but not corticosterone
Systemic inflammation has been shown to increase
circulating cytokines, and stress is known to decrease
pro-inflammatory cytokine expression via glucocorticoid
induction [55]. As mentioned above, the levels of pro-
inflammatory cytokines present 24 h after injection of
0.1 mg/kg endotoxin should be relatively low [56].
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In this experiment, both LPS and stress had a significant
effect on TNFα gene expression; furthermore, there was a
significant interaction between the factors (Fig. 5a; two-
way ANOVA; stress p < 0.01 F1,18 = 9.259; LPS p < 0.001
F1,18 = 22.07; stress:LPS p < 0.05 F1,18 = 6.472). At 24 h
after LPS injection in non-stressed mice, the fivefold
increase in hepatic Tnf compared to vehicle-treated con-
trols was statistically significant (Fig. 5a; Bonferroni post
hoc; p < 0.001). Chronic stress and LPS, combined, ap-
peared to the levels of TNFα mRNA compared to vehicle
controls, but this change was not significant (Fig. 5a).
IL-1β mRNA expression was affected by stress and
LPS, but there was no significant interaction
between the two factors (Fig. 5b; two-way ANOVA;
stress p < 0.001 F1,18 = 15.56; LPS p < 0.01 F1,18 =
12.61; stress:LPS p = 0.07 F1,18 = 3.711). IL-1β mRNA
expression was slightly higher in animals treated
with stress and LPS alone but in neither case are
they significantly different from non-stressed,
vehicle-treated controls (Fig. 5b). The combination
of 10 days of chronic stress and a low-dose LPS
challenge resulted in a significant sixfold increase in
hepatic IL-1β mRNA expression (Fig. 5b; Bonferroni
post hoc; p < 0.001).
Control animals had an average of 10-nM baseline
corticosterone (Fig. 5c). Both stress and LPS had a
A B
C D
E F
Fig. 4 The effect of low-dose LPS on anxiety and aggression-like behaviours in stressed mice. Naïve and stressed animals were challenged with a
single dose of LPS (0.1 mg/kg) or vehicle (saline) and tested 24 h thereafter in the elevated O-maze for the a latency to exit to the open arms
and b number of exits to the open arms; in the resident-intruder paradigm for c duration of social interaction and d latency to attack conspecific,
e total number of attacks and f duration of crawl over behaviour. Data are mean ± SEM; *p < 0.05, **p < 0.01 and ***p < 0.001 compared to control
animals; +++p < 0.001 and ++++p < 0.0001 compared to stressed animals
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significant effect on corticosterone levels, and there
was a significant interaction between these factors
(Fig. 5c; two-way ANOVA; stress p < 0.05 F1,25 = 4.605;
LPS p < 0.01 F1,25 = 9.355; stress:LPS p < 0.05 F1,25 =
6.659). More specifically, analysis showed that admin-
istration of 0.1 mg/kg LPS significantly increased
circulating corticosterone when compared to controls,
to an average of 90 nM (Fig. 5c; Bonferroni post hoc;
p < 0.01). Following 10 days of stress and 10 days of
stress in combination with an LPS challenge, elevated
circulating corticosterone levels (100 nM) were also
found and were significantly higher than controls
(Fig. 5c; Bonferroni post hoc; stress alone p < 0.01,
stress and LPS p < 0.01). At no point were stressed or
LPS-treated animals different from each other, and
stress combined with LPS did not result in an addi-
tive increase in corticosterone concentration.
Low-dose LPS-induced inflammation does not exacerbate
chronic stress-induced changes in 5-HT2A and SERT
expression or CNS cytokine expression
Previous work from our laboratory has demonstrated
that both LPS and chronic stress are independently cap-
able of changing the expression of the 5-HT2A receptor
and SERT mRNA expression [29, 35]. The data above
demonstrate that LPS is capable of exacerbating certain
behaviours induced by the chronic stress. Therefore, it is
important to determine whether receptor expression was
also cumulatively increased or whether, like cortico-
sterone, low-level inflammation in stressed animals did
not affect receptor expression. The addition of both
stress and LPS into the model requires a more complex
analysis with stress, LPS and brain regions as repeated
factors. The general linear model applied to the earlier
data remains with unstructured co-variance but with the
added capacity of determining whether stress and LPS
interact with each other. The number of possible inter-
actions makes reporting this data rather excessive; there-
fore, only significant values are reported below.
IL-1β mRNA levels were significantly affected by both
stressors, either stress or LPS alone or combined and by
brain region (Fig. 6a; RM-ANOVA brain region p < 0.001
F4,48 = 16.91; stress:LPS:brain region p < 0.001 F4,48 =
13.69). These factors also showed a significant inter-
action, suggesting that stress/LPS had a differential effect
A
B
C
Fig. 5 Cytokine mRNA in the liver and blood corticosterone levels in
control, stressed and LPS-treated animals. mRNA levels of a TNFα and b
IL-1β were measured by qPCR in the liver of animals after either 10 days
of chronic stress, an acute LPS challenge (0.1 mg/kg) or a combination of
both. Corticosterone levels in blood (c) were measured by HPLC. qPCR
data are expressed as relative-fold expression normalized to GAPDH and
naïve mice. Bars are mean ± SEM, (n= 5 in each group), **p< 0.01 and
***p< 0.001 compared to control animals
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on IL-1β mRNA levels in different brain regions (Fig. 6a;
brain region:stressor p < 0.001 F4,48 = 8.58). Post hoc test-
ing revealed significant effects of LPS alone, and stress
combined with LPS, in the dorsal raphe nucleus (Fig. 6a;
Bonferroni post hoc; p < 0.001 stress vs LPS; p < 0.05
control vs stress and LPS), and these differences contin-
ued in the raphe when comparing animals that were
only stressed for 10 days to animals that were stressed
but also challenged with LPS (Fig. 6a; Bonferroni post
hoc p < 0.001). Other brain regions only showed minor
increases in IL-1β receptor mRNA expression after ei-
ther stress or LPS, and these did not reach significance
(Fig. 6a). However, it should be cautioned that large
changes in any individual brain region, such as the
raphe, are likely to mask smaller changes in other brain
regions.
In the brain, TNFα mRNA expression was affected in
a similar manner to IL-1β mRNA expression, with sig-
nificant main effects of both brain region and stressor
and a significant interaction (Fig. 6b; RM-ANOVA brain
region p < 0.05 F4,48 = 15.64; stressor p < 0.01 F4,48 = 7.72;
stress:LPS:brain region p < 0.05 F4,48 = 2.89). Post hoc
testing suggests that stress alone does not exacerbate
TNFα mRNA expression but as with the IL-1β results,
larger changes in other regions may mask specific ef-
fects. LPS administration induced a significant increase
in TNFα mRNA expression in all regions, with the ex-
ception of the hippocampus (Fig. 6b; Bonferroni post
hoc; pre-frontal cortex p < 0.0001; striatum p < 0.01;
raphe p < 0.0001). Stress combined with an inflammatory
challenge results in a significant increase in TNFα ex-
pression in similar regions compared to control (Fig. 6b;
Bonferroni post hoc; pre-frontal cortex p < 0.001; stri-
atum p < 0.01; raphe p < 0.05). Finally, there were signifi-
cant differences between stress-alone animals and
animals stressed and challenged with LPS but only in
the pre-frontal cortex (Fig. 6b; Bonferroni post hoc p <
0.01). However, there was no overt synergy between
stress with LPS and LPS alone.
Analysis shows that there was only a significant main
effect of brain region on 5-HT2A mRNA expression, as
well as a significant interaction between brain region,
stress and LPS challenge (Fig. 6c; RM-ANOVA brain re-
gion p < 0.001 F4,48 = 16.20; stress:LPS:brain region p <
0.01 F4,48 = 4.96). Post hoc analysis shows 5-HT2A recep-
tor mRNA expression appeared to increase after a single
A B
C D
Fig. 6 IL-1β, TNFα, 5-HT2A receptor and SERT mRNA expression in the brain structures of animals challenged with chronic stress, LPS or a combination
of both. mRNA levels of a IL-1β, b TNFα, c 5-HT2A and d SERT were measured by qPCR in the pre-frontal cortex, striatum, hippocampus and raphe of
animals after either 10 days of chronic stress, an acute LPS challenge (0.1 mg/kg) or a combination of both. Values are expressed as relative-fold
expression normalized to housekeeping gene GAPDH and to control values within each region. Data are mean ± SEM; n = 5 in each group; *p < 0.05,
**p < 0.01, ***p < 0.001 and ****p < 0.0001 compared to control animals
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LPS injection in the pre-frontal cortex, striatum and
hippocampus, compared to controls, but was only
significantly different in the hippocampus (Fig. 6c;
Bonferroni post hoc; p < 0.01). There was no difference,
significant or otherwise, in 5-HT2A mRNA levels in the
raphe compared to controls (Fig. 6c). In a similar man-
ner, after 10 days of chronic stress, 5-HT2A mRNA ap-
peared to be elevated in the pre-frontal cortex as well as
the hippocampus but again, only reached significance in
the latter when compared to control animals (Fig. 6c;
Bonferroni post hoc; p < 0.01). Chronic stress did not
change receptor expression in either the striatum or the
raphe. In the CNS of animals challenged with 10 days of
chronic stress and LPS, 5-HT2A receptor mRNA expres-
sion was not different from controls in any region except
the hippocampus, where it showed an increase of a
similar magnitude to stress and LPS alone (Fig. 6c;
Bonferroni post hoc; p < 0.05).
SERT mRNA expression showed the same main effects
as for the 5-HT2A receptor, but significant interactions
were noted. Specifically, there was a main effect of brain
region and interactions between brain region and stress,
brain region and LPS challenge and all three factors
(Fig. 6d; RM-ANOVA; brain region p < 0.001 F4,48 =
22.23; stress:brain region p < 0.001 F4,48 = 15.46;
LPS:brain region p < 0.001 F4,48 = 6.42; stress:LPS:brain
region p < 0.01 F4,48 = 12.32). Further analysis showed
that SERT expression in the pre-frontal cortex after a
single LPS challenge appeared to be higher than controls
but did not reach significance (Fig. 6d; Bonferroni post
hoc pre-frontal cortex p = 0.081). No other brain regions
studied showed any change in SERT mRNA compared
to controls after a single dose of LPS. Ten days of
chronic stress did not change SERT expression in the
pre-frontal cortex or the raphe compared to controls but
led to significantly higher expression in the striatum and
hippocampus (Fig. 6d; Bonferroni post hoc; striatum p <
0.001, hippocampus p < 0.01). Compared to stress alone,
the combination of stress and LPS did give rise to any
significant increase SERT mRNA expression in any re-
gion studied (Fig. 6d).
Discussion
The studies reported here show that at a time when the
effects of an intraperitoneal injection of LPS are no lon-
ger detectable in naïve animals, the combination of LPS
with CMS increases depressive-like behaviours and in-
hibits the aggression and impulsivity induced by CMS.
The aggressive and impulsive behaviours were accom-
panied by SERT induction in the hippocampus, which
was ameliorated by the LPS treatment. The double-hit
combination had no effect on LPS-induced TNFα ex-
pression but did suppress LPS-induced IL-1β mRNA
expression. Overall, SERT upregulation, rather than 5-
HT2A or the pro-inflammatory cytokines, appears to cor-
relate with the stress-induced aggressive and impulsive
behaviours. A similar independent increase in SERT was
previously reported in stressed animals that become an-
hedonic [29]. Here, hepatic TNFα and IL-1β mRNA
levels differed between stressed mice injected with LPS
compared to LPS alone in a surprising manner revealing
a dissociation between the regulation of TNFα and IL-
1β mRNA expression. Moreover, these changes in hep-
atic cytokine expression appeared to be independent of
corticosterone induction. These results are discussed in
more detail below.
Using a low-dose LPS challenge after stress in both
the sucrose preference test and the forced swim test, we
showed that the downstream sequelae of a peripheral in-
flammatory response appeared to exacerbate the anhe-
donia and helplessness induced by stress. Indeed, there
was significant synergy for a reduction in sucrose intake.
Non-stressed mice exhibit polydipsia, and this in known
to be reduced by stress [57] and is further reduced by
the LPS challenge, indicating that low levels of systemic
inflammation that may not generate overt clinical signs
per se can synergize with a stress-induced depressive ill-
ness and provoke a worsening phenotype. Thus, the
diagnosis and treatment of low-grade inflammatory dis-
ease in patients may reduce some select depressive signs
by mechanisms that are independent of those that are
associated with major depression and those targeted by
traditional antidepressants. Others have shown that the
combination of endotoxin with stress in mice can result
in increased mortality [58] but such severe experiments
(40 mg/kg LPS compared to 0.1 mg/kg in our studies)
did not set out to explore the subtle relationship be-
tween low-level infection and stress. In rats, lower levels
of endotoxin were previously used to discover how
inescapable shock-induced stress would be altered
[59, 60]. In these experiments, the febrile response asso-
ciated with inescapable shock and LPS was increased and
this was associated with enhanced pro-inflammatory cyto-
kine responses. As in our experiments, Johnson et al. [60]
found the relationship between cytokine expression and
the double-hit of stress and inflammation was not a
straightforward relationship; enhanced pro-inflammatory
cytokine responses where not necessary to observe
enhanced HPA or fever responses after LPS and inescap-
able tailshock.
Work studying the immune response after a stressful
event has suggested that stress ‘primes’ the inflammatory
response for an immune challenge, making it more sensi-
tive [15]. The depressive-like behaviours associated with
an LPS challenge have also been shown to be ameliorated
by imipramine and fluoxetine given prior to LPS adminis-
tration [61], and our results suggest that while antidepres-
sants might target the post-infection component of the
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combination, anti-inflammatory therapy might also be
beneficial. Indeed, celecoxib administered as an adjunctive
non-steroidal anti-inflammatory drug (NSAID) appears to
produce a positive therapeutic outcome in the treatment
of depression [62].
In this study, although chronically stressed mice ex-
hibit anhedonia, they also display increased rates of ag-
gressive behaviour in the resident-intruder test where
attacking and crawl over behaviours were markedly in-
creased. Crawl overs have been investigated in rats and
form part of juvenile play fighting. However, such behav-
iour has also been observed in aggressive encounters. In
rats, crawl overs occur when the rats are unfamiliar with
one another and seem to be important in establishing
dominance [45]. Such stress-induced changes in attack
frequency have been previously described using the same
CMS regime as employed here [36]. A paradoxical
‘anxiolytic-like profile’, manifest as increased impulsivity
in the elevated O-maze, was also observed in response
to stress, in line with previously reported findings [63].
In contrast, stressed mice subjected to a low-level LPS
challenge displayed a reduction in aggressive behaviour
in the resident-intruder test and no signs of impulsivity/
hyperlocomotion in the elevated O-maze. In studies of
aggression and impulsivity, the combination of stress
and low-level inflammation therefore appears to coun-
teract, rather than exacerbate, the negative effects of
stress on behaviour.
Changes in measures of aggressiveness and impulsiv-
ity/hyperactivity were accompanied by differential ex-
pression of SERT in the brain. In the hippocampus,
mRNA levels of SERT were increased in chronically
stressed mice. In stressed mice challenged with LPS, ex-
pression levels of SERT in the hippocampus did not
change, but they did tend towards a decrease in the pre-
frontal cortex. Chronically stressed mice without expos-
ure to LPS displayed a non-significant increase in SERT
expression in the pre-frontal cortex. These data are in
accordance with our previous observations [30]. Elevated
SERT expression was previously reported in mice dis-
playing aggressive behaviour induced by repeated social
confrontation stress [64]. The increase in SERT in the
limbic structures of the brain is frequently found after
stressors of various types [65]. In contrast, a decrease in
SERT expression in similar structures was shown to be a
molecular correlate of clinical depression [66] and of an
experimentally induced depressive-like state in animals
[67]. These data, in combination with our own, suggest
changes in molecular signals within specific brain re-
gions may result in behaviourally distinct outcomes.
In vitro and in vivo studies have shown that pro-
inflammatory cytokines, such as IL-1β and TNFα, can
increase SERT activity via the p38 MAPK signalling
pathway [46]. Behavioural signs of helplessness resulting
from circulating cytokines have been shown to be pre-
vented by a blockade of SERT [68]. Furthermore, SERT
mutant rats show abnormal behaviour (including de-
creased sucrose preference, decreased spontaneous ac-
tivity and increased anxiety [69]) and CNS cytokine
expression profiles in response to LPS [70]. In humans,
however, the reverse appears to be true. Clinical studies
reveal that decreased SERT function, associated with the
short variant of the SERT gene and lower SERT activity,
correlates with an increased risk of developing depres-
sion during IFN-α treatment [71]. Indeed, our own work
has demonstrated that there is no change in the release
of 5-HT in response to LPS, suggesting a post-synaptic
mechanism may be more crucial to sickness behaviour
[72]. Thus, the relationship between SERT activity and
responsiveness to pro-inflammatory factors in the regu-
lation of depression pathogenesis appears to be complex
and is liable to explain the differences we observed in
aggressive behaviour associated with stress alone vs
stress in combination with an inflammatory challenge.
The levels of 5-HT2A mRNA were different in mice
subjected to stress alone to those additionally challenged
with LPS. Previously, elevation of 5-HT2A in the limbic
structures was documented as an important correlate of
a depressive-like state, which represents a target for
pharmacological treatment [73]. In line with our previ-
ous observations [29, 72], such changes were found in
the pre-frontal cortex of stressed mice but not in naïve
or stressed mice injected with LPS. However, a signifi-
cant elevation of 5-HT2A expression was detected in the
hippocampus of the two latter groups, in line with simi-
lar findings elsewhere showing that inflammation signifi-
cantly affects 5-HT2A [35, 74]. The similarities in
receptor expression profiles regardless of stress exposure
suggest that changes in the expression of the 5-HT2A re-
ceptor are unlikely to mediate the exacerbated behav-
ioural effects observed in the double-hit mice.
Importantly, our low-dose LPS challenge in naïve
animals resulted in the over-expression of TNFα in
several brain structures, including the pre-frontal cor-
tex, but this was not associated with alteration in the
behaviours tested. Such findings are in accord with
previously published results, showing that cytokine
over-expression exerts minimal effects on social be-
haviour in rodents [56]. The expression of IL-1β in
the dorsal raphe nucleus was significantly elevated in
both naïve and stressed LPS-treated groups. However,
this effect is also unlikely to underlie behavioural dif-
ferences between chronically stressed mice, with or
without LPS challenge, since naïve mice showed no
obvious behavioural changes in aggression or
depressive-like behaviours.
Stress is well known to increase circulating cortisol,
and there is evidence linking cortisol levels and
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depression. Depressed patients frequently show dexa-
methasone non-suppression, suggesting hyperactivity of
the Hypothalamic–pituitary–adrenal HPA axis [75]. Cor-
ticosterone levels are similar in animals subjected to ei-
ther CMS or LPS and thus could not explain the
phenotypic differences observed between stressed and
LPS-challenged animals. These data are in line with pre-
viously reported findings [76] although oddly, the in-
crease in corticosterone as a result of stress does not
appear to reduce the hepatic inflammatory response. This
data, and that in adrenalectomized animals, suggests that
the pro-inflammatory profile during stress is independent
of cortisol and may be the result of anti-inflammatory cy-
tokines and downstream signalling pathways [77].
Conclusions
Here, we have shown that the effects of chronic stress
and LPS are reflected by dissociated alterations in both
behaviour and gene expression, with elevated SERT ex-
pression appearing to be linked to stress-induced aggres-
sion. Furthermore, we have found that the molecular
and behavioural changes induced by stress or low-grade
inflammatory challenges are distinct and, when the chal-
lenges were combined, some of the behaviours syner-
gized and others, such as the aggressive behaviours,
were suppressed. It seems likely that distinct mecha-
nisms enabling the body to effectively deal separately
with stress vs infection have evolved but there is no
doubt that the presence of low-grade inflammation can
have a profound effect on stress-induced behaviours; the
underlying mechanisms are likely to be of relevance in
humans, where such combinations may precipitate de-
pressive episodes.
Additional file
Additional file 1: Table S1. Primer sequences for qPCR. Primers were
custom designed and validated by PrimerDesign Ltd. (Southampton, UK).
Figure S1. The effect of a low dose of LPS on locomotor activity at 24
and 48 h post-challenge in naïve mice. Naïve animals were subjected to
a single dose of LPS (0.1 or 0.5 mg/kg) or vehicle injection and were
tested at 24 or 48 h post-injection. (A) Neither the resting time was
unaltered by the treatment in the TruScan open field nor (B) rearing in
the novel cage test for the total number of rear. (C–E) Aggressive
behaviour was also unaltered. Data are mean ± SEM, two-way
ANOVA throughout. Figure S2. (A, B) Body weight in the chronic
stress experiment. Experimental groups were balanced upon
baseline mean values of body weight measured 7 days prior the
start of the chronic stress experiment and LPS challenge. Mice
exposed to chronic stress had a significant reduction in body
weight as compared with baseline measurements (*p < 0.05,
pairwise t test). Chronically stressed mice injected either with
vehicle or LPS had similar mean body weight prior the LPS
challenge. (C–E) Sucrose preference. Experimental groups were
balanced upon baseline mean values of sucrose preference when
evaluated 7 days prior the experiment chronic stress procedure and
LPS challenge. Experimental groups had similar mean measures of
sucrose and water intake. (p > 0.05, one-way ANOVA and post hoc
Tukey test; see the text). (F) Naïve and stressed animals (10 days)
were challenged with a single dose of LPS (0.1 mg/kg) or vehicle
(saline) and tested 24 h thereafter in a novel cage test for total
number of rears (see the text). Data are mean ± SEM. No differences
between the groups were observed. Figure S3. (A–C) Baseline
behaviour in a resident-intruder test. Experimental groups were
balanced upon baseline mean scores of behaviours in a resident-intruder
test that were studied 7 days prior the experimental chronic stress procedure
and LPS challenge. Mice had similar mean measures of (A) latency to attack,
(B) number of attack and (C )duration of crawl over behaviour. (p > 0.05,
one-way ANOVA and post hoc Tukey test; see the text). (D) The latency to
attack after the chronic stress was not significantly altered.
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